The OLD-DOG Project enrolled 209 privately owned dogs aged 5+ years to identify aging biomarkers through comprehensive evaluations every six months, measuring physiological, biochemical, hematological parameters, microbiota profiles, telomere length, and DNA methylation patterns. Preliminary analyses revealed consistent age-related patterns across multiple biological domains, including inflammatory markers and physical performance metrics. This ambitious validation study addresses a critical gap in aging research methodology. Dogs offer unique advantages as aging models—they share human environments, receive similar medical care, and have accelerated lifespans allowing faster data collection compared to human cohorts. The project's comprehensive biomarker approach, from cellular markers like telomeres to behavioral assessments, could establish standardized metrics for translating aging interventions from laboratory to clinic. However, genetic diversity between dog breeds and species-specific differences in metabolism and physiology may limit direct human applicability. If successful, this validation could accelerate aging research by providing a reliable, ethically sound model for testing interventions, potentially reducing the decades-long timeline needed for human longevity studies to just a few years of canine research.